
A study in The Journal of Bone & Joint Surgery suggests that individuals with knee pain who use beta-blockers, a common blood pressure medication, may have a reduced risk of undergoing total knee arthroplasty (TKA) for advanced osteoarthritis (OA). This case-control study, conducted in Spain, found that non-selective beta-blockers, which target both beta-I and beta-2 adrenergic receptors, were associated with a 54% reduced risk of TKA. Longer-term use of beta-blockers (five years or more) resulted in a 64% reduction in TKA risk. This study provides insights into potential OA treatment approaches targeting the adrenergic system.
Like
Save
Share